Consultant pharmacists’ expertise should not be restricted to hospital patients, Society tells Darzi

Lord Darzi is reviewing the NHS |
The expertise of NHS consultant pharmacists should be available to all patients with complex conditions whether or not they are admitted to hospital, the Royal Pharmaceutical Society suggests in its submission to the NHS Next Stage Review for England.
(PDF 40K)
The suggestion forms part of a series of proposals centred round the
premise that health services should be designed to meet patients’ needs
rather than according to sectoral and organisational boundaries.
“Services should be organised so that patients can access pharmacists’ expertise
when and where they need it. … Many patients with complex conditions
who are not admitted to hospital could benefit from [NHS consultant pharmacists’]
expertise,” the Society states.
The policy proposals are set out in a letter to health minister Lord
Darzi of Denham by Society President Hemant Patel and chairman of the
Society’s English Pharmacy Board Paul Bennett. They argue that
pharmacy can do more than just shift services to a different location
or deliver them more cheaply.
“It can redesign services and repackage combinations of services
differently to meet patients’ needs and preferences, for example,
by providing expert advice, therapeutic monitoring and screening tests
at a convenient
time for the service user,” Mr Patel and Mr Bennett say.
They also point out that the pharmacy workforce can create and spread
innovative services. “Community pharmacies are businesses: they
have the structural and cultural flexibility to roll out significant
changes very rapidly.”
In addition to the need to redesign services, they identify the need
to increase integration of pharmacy services with other health services.
“The pharmacist must be accepted as a full member of the local
health team if their skills are to be effectively deployed,” they
say, adding that “services such as medicines use reviews need to
be integrated with GP care to benefit patients fully”.
They also suggest that GP practices should be given an incentive to employ
sessional pharmacists to work on prescribing quality and cost-effectiveness.
|